Geron Stock Performance
| GERN Stock | USD 3.73 0.04 1.08% |
Geron holds a performance score of 9 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.45, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Geron will likely underperform. Use Geron value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on Geron.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Geron are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Geron displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.3 | Five Day Return 3.99 | Year To Date Return 76.4 | Ten Year Return 82.37 | All Time Return (48.50) |
Last Split Factor 1058:1000 | Last Split Date 2014-07-22 |
1 | Geron Co. Shares Bought by Rafferty Asset Management LLC - MarketBeat | 02/20/2024 |
2 | Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate Too... | 03/05/2024 |
3 | FDA committee favors Gerons imetelstat for certain blood cancer | 03/14/2024 |
4 | STAT I was wrong about Gerons blood cancer drug. Now, is it a takeover target | 03/18/2024 |
5 | Geron Corporation Announces Pricing of 150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants | 03/19/2024 |
6 | Biotech Stock Roundup GERN, CRNX Gain on Updates, BMYs CAR T Cell Therapy News More | 03/21/2024 |
7 | Geron Co. Sees Large Growth in Short Interest - MarketBeat | 04/02/2024 |
8 | Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635 - The Globe and Mail | 04/05/2024 |
9 | The Latest Analyst Ratings For Geron - Geron - Benzinga | 04/10/2024 |
10 | Acquisition by Ofarrell Elizabeth G. of 125000 shares of Geron at 3.27 subject to Rule 16b-3 | 04/12/2024 |
11 | Geron Co. Short Interest Down 8.4 percent in March - MarketBeat | 04/15/2024 |
12 | Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 04/18/2024 |
13 | Acquisition by Robert Spiegel of 125000 shares of Geron at 3.27 subject to Rule 16b-3 | 04/22/2024 |
| Begin Period Cash Flow | 57.2 M |
Geron |
Geron Relative Risk vs. Return Landscape
If you would invest 208.00 in Geron on January 24, 2024 and sell it today you would earn a total of 165.00 from holding Geron or generate 79.33% return on investment over 90 days. Geron is currently generating 1.494% in daily expected returns and assumes 12.6855% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Geron, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Geron Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Geron's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Geron, and traders can use it to determine the average amount a Geron's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1178
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | GERN | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.69 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.49 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Geron is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Geron by adding it to a well-diversified portfolio.
Geron Fundamentals Growth
Geron Stock prices reflect investors' perceptions of the future prospects and financial health of Geron, and Geron fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Geron Stock performance.
| Return On Equity | -1.12 | ||||
| Return On Asset | -0.41 | ||||
| Current Valuation | 1.77 B | ||||
| Shares Outstanding | 588.87 M | ||||
| Price To Earning | (12.48) X | ||||
| Price To Book | 8.64 X | ||||
| Price To Sales | 9,032 X | ||||
| Revenue | 237 K | ||||
| Gross Profit | (93.67 M) | ||||
| EBITDA | (192.91 M) | ||||
| Net Income | (184.13 M) | ||||
| Cash And Equivalents | 219.29 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 85.9 M | ||||
| Debt To Equity | 0.39 % | ||||
| Current Ratio | 4.85 X | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | (167.1 M) | ||||
| Earnings Per Share | (0.32) X | ||||
| Market Capitalization | 2.17 B | ||||
| Total Asset | 394.08 M | ||||
| Retained Earnings | (1.6 B) | ||||
| Working Capital | 233.28 M | ||||
| Current Asset | 115.89 M | ||||
| Current Liabilities | 6.63 M | ||||
About Geron Performance
To evaluate Geron Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Geron generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Geron Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Geron market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Geron's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -1.5 K | -1.4 K | |
| Return On Tangible Assets | (0.47) | (0.49) | |
| Return On Capital Employed | (0.68) | (0.71) | |
| Return On Assets | (0.47) | (0.49) | |
| Return On Equity | (0.74) | (0.78) |
Things to note about Geron performance evaluation
Checking the ongoing alerts about Geron for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Geron help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Geron is way too risky over 90 days horizon | |
| Geron appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 237 K. Net Loss for the year was (184.13 M) with loss before overhead, payroll, taxes, and interest of (93.67 M). | |
| Geron currently holds about 219.29 M in cash with (167.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Geron has a very weak financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635 |
- Analyzing Geron's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Geron's stock is overvalued or undervalued compared to its peers.
- Examining Geron's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Geron's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Geron's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Geron's stock. These opinions can provide insight into Geron's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Geron Stock analysis
When running Geron's price analysis, check to measure Geron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Geron is operating at the current time. Most of Geron's value examination focuses on studying past and present price action to predict the probability of Geron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Geron's price. Additionally, you may evaluate how the addition of Geron to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Geron's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Quarterly Revenue Growth (0.78) | Return On Assets (0.41) | Return On Equity (1.12) |
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.